Amicus Therapeutics Inc
(LTS:0HF9)
$
10.0592
0.0812 (0.81%)
Market Cap: 2.98 Bil
Enterprise Value: 3.17 Bil
PE Ratio: 0
PB Ratio: 16.66
GF Score: 81/100 Amicus Therapeutics Inc at Bank of America Global Healthcare Conference Transcript
May 11, 2023 / 03:40PM GMT
Release Date Price:
$11.09
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
Okay, everybody. Good morning. Thanks for joining us here in Las Vegas at the Bank of America Healthcare Conference. I'm Tazeen Ahmad, I'm one of the senior biotech analysts here. It's my pleasure to have with me on stage. Amicus Therapeutics speaking for Amicus for the next half hour is, of course, President and CEO, Brad Campbell. Brad, thanks for making the trip out here.
Bradley L. Campbell
Amicus Therapeutics, Inc. - CEO, President & Director
Thank you for having us, Tazeen. Thanks to Bank of America for hosting good-to-see people.
Questions & Answers
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
And so I think this is a timely conversation for us to have. You did share some good news, the long-awaited inspection of your Wuxi facility in preparation for final approval for Pompe, so maybe talk to us about, obviously, what went into that inspection and
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot